FIELD: medicine.
SUBSTANCE: method involves measuring internal temperature of mammary gland tissue at nine symmetrically located points on both sides and in tumor projection point under visual control by applying radiothermometry approach. Mean internal temperature of mammary gland tissue value is shown on computer analyzer image. It is taken as reference value. The value measured in the tumor projection point is compared to the reference one and its excess with respect to the reference value is determined. The value being equal to or less than 0.5, no focal hyperthermia conclusion is drawn and the tumor is considered to be benign. The value being equal to 0.6-0.9, focal hyperthermia is thought not to be expressed and boundary stage of tumor process is diagnosed. The value being greater than 1.0, malignant tumor is considered to be the case.
EFFECT: high accuracy of differential diagnosis.
Title | Year | Author | Number |
---|---|---|---|
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BENIGN AND MALIGNANT BREAST PATHOLOGIES | 2013 |
|
RU2532372C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR DEGREE OF MANIFESTATION OF DIFFUSE MASTOPATHY | 2008 |
|
RU2364327C1 |
METHOD FOR SCREENING DIAGNOSIS OF MALIGNANT OVARIAN NEOPLASMS FOR POSTMENOPAUSAL WOMEN | 2016 |
|
RU2616989C1 |
METHOD FOR PREDICTING FORMATION OF CAPSULAR CONTRACTURE AFTER ENDOPROSTHETICS OF MAMMARY GLANDS | 2015 |
|
RU2616211C1 |
METHOD FOR PREDICTING GROWTH TEMPO OF MALIGNANT MAMMARY TUMOR | 2005 |
|
RU2283023C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HYPERPLASIA, INTRAEPITHELIAL NEOPLASIAS AND CERVIX UTERI CANCER | 2005 |
|
RU2321859C2 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CARCINOGENESIS STAGES | 2003 |
|
RU2234099C1 |
METHOD OF ESTIMATING EFFICIENCY OF DIFFUSE MASTOPATIA TREATMENT | 2010 |
|
RU2449724C1 |
METHOD FOR BREAST CANCER SCREENING AND PREDISPOSITION TO IT | 2019 |
|
RU2705344C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPMENT OF FEMALE GENITAL NEOPLASMS | 2018 |
|
RU2687780C1 |
Authors
Dates
2007-10-10—Published
2006-03-28—Filed